Overview
Chronic myeloid leukemia (CML) is a cancer of the blood and bone marrow in which immature white blood cells of the myeloid line are overproduced. It is driven by a characteristic genetic change, the Philadelphia chromosome, formed by a translocation between chromosomes 9 and 22 that creates the BCR-ABL fusion gene. The resulting abnormal protein keeps cells dividing without normal control. CML often progresses slowly through phases and has been transformed by targeted tyrosine kinase inhibitors that block BCR-ABL activity. Research in Hematology and Oncology Research engages CML directly. One qualitative study examines the drivers and barriers to medication adherence in patients with chronic myeloid leukemia, addressing a key factor in the success of long-term targeted therapy. Another describes the evolution of a Janus kinase 2 V617F-negative idiopathic myelofibrosis into Philadelphia-positive chronic myeloid leukemia, while a further case reports a patient with monoclonal gammopathy of undetermined significance in whom the Philadelphia chromosome was detected. Together these contributions span clinical management, disease evolution, and diagnostic findings in CML. This page gathers peer-reviewed, open-access research relevant to chronic myeloid leukemia, supporting clinicians, researchers, and students concerned with the biology and treatment of this hematologic malignancy.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Evolution of Janus Kinase 2 V617F-negative idiopathic myelofibrosis into Philadelphia+ chronic myeloid leukemia
A Patient with Monoclonal Gammopathy of Undetermined Significance and Detected Philadelphia Chromosome
Study of Neuropilin-1/Cd304 Expression in Leukemogenesis
Immune Thrombocytopenia after Allogeneic Stem Cell Transplantation: Case Report and Brief Overview of Treatment Strategies
Molecular Cytogenetic Investigations in a Novel Chromosomal Abnormality of t(10;15)(q22;q22) in a Pediatric Precursor-B-Acute Lymphoblastic Leukemia Patient
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
Splenectomy Reports
How this research is being cited
The 8 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · European Journal of Cancer Care
-
2023 · European Journal of Oncology Nursing
-
2023 · European Journal of Oncology Nursing
-
2023 · European Journal of Cancer Care
-
2022 · Hematology/Oncology and Stem Cell Therapy
-
2020 · Hematology/Oncology and Stem Cell Therapy
-
2020 · Leukemia & lymphoma/Leukemia and lymphoma
-
2019 · The Egyptian Journal of Hospital Medicine
A sample of recent works citing this journal's research on Chronic Myeloid Leukemia, linking to each citing work.